Next Article in Journal
Immunoregulatory Functions of the IL-12 Family of Cytokines in Antiviral Systems
Previous Article in Journal
Structural Insights on Retroviral DNA Integration: Learning from Foamy Viruses
Previous Article in Special Issue
Hurdles for Phage Therapy to Become a Reality—An Editorial Comment
Open AccessComment

Comment on Fauconnier, A. Phage Therapy Regulation: From Night to Dawn

1
Office of Anti-Infectives and Vaccines, Human Medicines Evaluation Division, European Medicines Agency, 1083 HS Amsterdam, The Netherlands
2
Regulatory Affairs Office, Human Medicines Evaluation Division, European Medicines Agency, 1083 HS Amsterdam, The Netherlands
*
Author to whom correspondence should be addressed.
Viruses 2019, 11(9), 771; https://doi.org/10.3390/v11090771
Received: 18 July 2019 / Revised: 2 August 2019 / Accepted: 16 August 2019 / Published: 22 August 2019
(This article belongs to the Special Issue Hurdles for Phage Therapy (PT) to Become a Reality)
Note: In lieu of an abstract, this is an excerpt from the first page.

With most interest we read the contribution made by Fauconnier on phage therapy regulation [...] View Full-Text
Keywords: antimicrobial resistance; bacteriophage; personalised medicines; phage therapy; pharmaceutical legislation; regulatory framework antimicrobial resistance; bacteriophage; personalised medicines; phage therapy; pharmaceutical legislation; regulatory framework
MDPI and ACS Style

Pelfrene, E.; Sebris, Z.; Cavaleri, M. Comment on Fauconnier, A. Phage Therapy Regulation: From Night to Dawn. Viruses 2019, 11, 771.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop